×

Before you go!

Sign up for the FREE weekly email newsletter from the publishers of American Nurse Today. You’ll get breaking news features, exclusive investigative stories, and more — delivered to your inbox.

Sign up today!

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
Cardiovascular

FDA releases safety review update report for Benicar

As part of a safety review update on cardiovascular events and Benicar (olmesartan), the U.S. Food and Drug Administration states Benicar’s benefits “continue to outweigh its potential risks when used for the treatment of patients with high blood pressure according to the drug label http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=benicar&SearchType=BasicSearch. Read more at http://www.fda.gov/Drugs/DrugSafety/ucm251268.htm.


Leave a Reply

You have to agree to the comment policy.

 

Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing

Shares